Literature DB >> 10094933

Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage.

D Larocca1, P D Kassner, A Witte, R C Ladner, G F Pierce, A Baird.   

Abstract

We have genetically modified filamentous bacteriophage to deliver genes to mammalian cells. In previous studies we showed that noncovalently attached fibroblast growth factor (FGF2) can target bacteriophage to COS-1 cells, resulting in receptor-mediated transduction with a reporter gene. Thus, bacteriophage, which normally lack tropism for mammalian cells, can be adapted for mammalian cell gene transfer. To determine the potential of using phage-mediated gene transfer as a novel display phage screening strategy, we transfected COS-1 cells with phage that were engineered to display FGF2 on their surface coat as a fusion to the minor coat protein, pIII. Immunoblot and ELISA analysis confirmed the presence of FGF2 on the phage coat. Significant transduction was obtained in COS-1 cells with the targeted FGF2-phage compared with the nontargeted parent phage. Specificity was demonstrated by successful inhibition of transduction in the presence of excess free FGF2. Having demonstrated mammalian cell transduction by phage displaying a known gene targeting ligand, it is now feasible to apply phage-mediated transduction as a screen for discovering novel ligands.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094933     DOI: 10.1096/fasebj.13.6.727

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  37 in total

Review 1.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

Review 2.  Bacteriophages and medical oncology: targeted gene therapy of cancer.

Authors:  Babak Bakhshinejad; Marzieh Karimi; Majid Sadeghizadeh
Journal:  Med Oncol       Date:  2014-07-11       Impact factor: 3.064

3.  Open reading frame mining identifies a TLR4 binding domain in the primary sequence of ECRG4.

Authors:  Xitong Dang; Raul Coimbra; Liang Mao; Sonia Podvin; Xue Li; Hua Yu; Todd W Costantini; Xiaorong Zeng; Dana Larocca; Brian P Eliceiri; Andrew Baird
Journal:  Cell Mol Life Sci       Date:  2019-06-12       Impact factor: 9.261

4.  Gene transfer into Mammalian cells using targeted filamentous bacteriophage.

Authors:  Andrew Baird
Journal:  Cold Spring Harb Protoc       Date:  2011-08-01

5.  Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.

Authors:  Andrew Baird; Brian P Eliceiri; Ana Maria Gonzalez; Conrad E Johanson; Wendy Leadbeater; Edward G Stopa
Journal:  Methods Mol Biol       Date:  2011

6.  Recombinant lambda-phage nanobioparticles for tumor therapy in mice models.

Authors:  Amir Ghaemi; Hoorieh Soleimanjahi; Pooria Gill; Zuhair Hassan; Soodeh Razeghi M Jahromi; Farzin Roohvand
Journal:  Genet Vaccines Ther       Date:  2010-05-12

7.  Targeting the gut barrier: identification of a homing peptide sequence for delivery into the injured intestinal epithelial cell.

Authors:  Todd W Costantini; James G Putnam; Ritsuko Sawada; Andrew Baird; William H Loomis; Brian P Eliceiri; Vishal Bansal; Raul Coimbra
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

Review 8.  Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

Authors:  Mahdi Karimi; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Sajad Bahrami; Mohsen Moghoofei; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2016-03-17       Impact factor: 15.470

9.  A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer.

Authors:  Martin Trepel; Charlotte A Stoneham; Hariklia Eleftherohorinou; Nicholas D Mazarakis; Renata Pasqualini; Wadih Arap; Amin Hajitou
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

10.  Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain.

Authors:  Stefania Piersanti; Gioia Cherubini; Yuri Martina; Barbara Salone; Daniele Avitabile; Fabiana Grosso; Enrico Cundari; Giovanni Di Zenzo; Isabella Saggio
Journal:  J Mol Med (Berl)       Date:  2004-05-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.